- Email Us
Connect With Us
Hepatitis C is a viral infection that affects the liver mainly and can lead to chronic liver disease, cirrhosis, and hepatocellular carcinoma (liver cancer) if it is not detected and treated. The infection is, in most cases, silent in its early stages, hence the need for a simple blood test that can easily identify those exposed to the virus before extensive liver damage has occurred.
Screening is performed using the Hepatitis C Virus Antibody test. This investigation is the pivotal moment to a subsequent diagnostic algorithm aimed at recognising past exposure to Hepatitis C Virus (HCV) and thereby allowing the necessary follow-up to ensure liver health is maintained in the long run.
The Anti HCV Ab test, or anti-HCV test, is a widely used blood test that identifies the presence of antibodies to the Hepatitis C virus in a person's blood. Antibodies are proteins produced by the immune system that target specific foreign invaders, in this case, the virus.
The coexistence of antibodies implies that the human being has been in contact with the HCV.It is important to note that the anti-HCV Ab test detects immune memory, not the virus itself (viral RNA). A positive result only indicates that the person has been exposed to the virus at some point and doesn't indicate whether the infection is still present or has been resolved (the body has naturally eliminated the virus).
Approximately 15%-25% of the population who are exposed to the hepatitis C virus will clear the virus without treatment. Thus, any positive anti-HCV Ab test result should be followed by another test, such as an HCV RNA test, to verify if the virus is still actively replicating in the body.
The anti HCV Ab test procedure is simple and based on the body's immune response to the Hepatitis C virus.
After the body encounters HCV, the immune system will make antibodies against the virus. Usually, these antibodies can be found in the blood within 8 to 10 weeks after infection.
However, this window period is not always the same.
A small blood sample is required for the test, typically drawn from a vein in the arm.
The procedure is very short; it only takes a few minutes and does not require any special preparation, such as fasting.
The blood sample is tested in the lab through advanced methods, and the most popular ones are enzyme immunoassay (EIA) or chemiluminescent immunoassay (CLIA).
The primary goal of these procedures is to identify antibodies against HCV antigens.
The outcome is either positive (reactive) or negative (non-reactive).
A positive result indicates the presence of HCV antibodies. When the anti HCV Ab test is positive, they will usually do an HCV RNA test from the same sample to confirm the diagnosis of an active infection.
The anti HCV Ab test is a tremendous public health tool and an individual liver care tool, which can be attributed to its several primary reasons:
Early detection and prevention of complications: Because a significant number of HCV patients remain asymptomatic for several decades, the test enables early detection of the disease.
Early detection can be followed by immediate intervention and treatment, which may lead to complete eradication of the infection and prevention of the progression of liver damage of any kind, including hepatocellular carcinoma and cirrhosis.
High-risk groups screening: The test is indispensable for the screening of possible HCV infection in people in high-risk groups. Among the risk factors, we can mention HCV-infected injected drug users.
People with abnormal liver enzymes, those receiving a blood transfusion or organ transplant before 1992. Following current recommendations, all adults should be tested for HCV at least once in their lifetime.
Definitive diagnosis confirmation: When using this test as the first diagnostic step, a favourable result leads to further testing (e.g., HCV RNA) to detect the presence of live viral particles and, hence, confirm an active infection.
This is a fundamental two-step process, both for a correct diagnosis and in decision-making whether the patient needs to receive antiviral therapy or not.
IIdentifying infected individuals enables medical professionals to inform patients about ways of preventing the transmission of the infection to other people, leading to lessening the spread of Hepatitis C spreading throughout the society.
Understanding the results of the anti-HCV Ab test by experts at Mahajan Imaging & Labs is a two step process, especially for reactive results:
The anti HCV Ab test is a qualitative screening test, so its normal values are considered just a status without any numerical range.
Normal (Negative) Value: The test is Non-Reactive. This is a favourable, normal outcome, indicating that no antibodies to the Hepatitis C virus have been detected.
Abnormal (Positive) Value: The test is Reactive. This finding is abnormal because it indicates that the person has been exposed to the virus and thus needs to be confirmed whether the infection is still active or not by further examination.
Uses of the Anti HCV Ab Test
The anti-HCV antibody test has been instrumental in both preventive and diagnostic medicine, especially in the area of liver health, as it accounts for various aspects such as:
Population Screening: It is the primary tool used to screen populations and high-risk groups for a history of HCV infection, consistent with public health guidance that all adults should be screened at least once.
Diagnosis of Symptoms: This test enables the diagnosis of Hepatitis C when the patient presents with nonspecific symptoms such as fatigue without a known cause, jaundice (yellowing of the skin/eyes), or persistently elevated liver enzymes (ALT/AST), which may indicate liver damage.
Pre-Surgical and Pre-Transplant Evaluation: The test is typically performed as part of pre-operative screening to determine the patient's HCV status, which informs planning for potential complications and the protection of medical staff.
Blood and Organ Donor Screening: The test is a critical safety measure for screening blood, organs, and tissues intended for donation to prevent inadvertent viral transmission to recipients.
Chronic Liver Disease Workup: The anti-HCV Ab test at Mahajan Imaging & Labs is a routine part of the diagnostic investigation of patients with chronic liver disease or cirrhosis of unknown origin.
Preparation for an anti HCV Ab test is kept to a bare minimum, thus allowing it to be easily accessible for screening:
No Fasting Necessary: Normally there is no need for fasting or changing your diet prior to the test.
Medication Disclosure: You should definitely tell your doctor about the medications, vitamins, and supplements you are taking. However, most of them do not interfere with the test.
Easy Blood Draw: The test is done through a standard venipuncture (blood draw from a vein), which is a short time procedure.
The anti HCV Ab test at Mahajan Imaging & Labs transcends being just a simple laboratory procedure; it is a it is a critical instrument against Hepatitis C and a milestone in the proactive management of liver health. Most of its worth is in the fact that it is able to detect exposure to the virus non-invasively, thus it is the indispensable first step in a diagnostic algorithm.
As a result of the test, the population which Hepatitis C slyly inflicts with irreversible liver damage is put under the early detection umbrella, thus individuals are given a chance for timely follow-up with the HCV RNA test and, if needed, obtaining curative antiviral treatment.
Due to improvements in direct-acting antiviral (DAA) drugs, Hepatitis C can now be cured. In this way, the anti HCV Ab test, by enabling early diagnosis, is a lifesaver as it prevents the deterioration of the liver disease stage and the occurrence of cancer, and it is indispensable for reaching the worldwide objective of HCV eradication.
Book your Anti HCV Ab test now with Mahajan Imaging & Labs to take the first step towards a comprehensive liver health assessment!
-1769166103.webp)
-1768990299.webp)
